Trump administration officials vetoed the FDA's plan to fast-track the review of a psychedelic treatment for severe ...

In a comparison of depression treatment trials, control group outcomes in trials of psilocybin were lower than those in trials of SSRIs and esketamine. This may suggest that psilocybin's ...

Psychedelics, psychoactive substances that alter people's perceptions, mood and thought patterns, have recently shown promise for the treatment of some mental health disorders, including depression ...

A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to two years, according to a new study. While the study has limitations, its ...

Two-thirds of participants in a small-scale clinical trial said they were in complete remission from depression five years later Interviews suggest the treatment helped patients see their depression ...

(The Center Square) – Mental health care providers are rediscovering new uses for old medicines. Recent findings demonstrating the efficacy of psilocybin, the active ingredient in magic mushrooms, ...

A new study published in the journal Psychedelics reveals that the environment and physiological state of an animal ...

Psilocybin has captured attention for its potential to ease depression and anxiety. But new findings from the University of California (UC), Davis, caution that psilocybin may not be a ...

Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to provide long-term treatment for depression and anxiety. But the chemical's ...

Researchers have developed a new model to study the antidepressant and anti-anxiety effects of psilocybin in mice.

Control group outcomes in randomized trials of psilocybin indicated less improvement in depression scores compared with trials of other antidepressants, according to a meta-analysis, suggesting that ...